At Rockley, we believe that our unique biosensing platform could be a game-changer for personal health management, transform healthcare, and improve people’s lives around the globe. By helping enable real-time insights, Rockley is well-positioned to revolutionize the way we manage our health and well-being for decades to come.
From wearable biosensing wristbands, chipsets, and algorithms to cloud-based analytics and AI, our end-to-end biomarker sensing platform includes a range of hardware and software solutions that enable the non-invasive, continuous, and real-time monitoring of multiple biomarkers.
Leveraging our world-class expertise in silicon photonics, we have miniaturized the capabilities of lab spectrometer into a compact form that can be integrated into wearable consumer devices and medical monitoring systems. This revolutionary breakthrough should enable three critical capabilities:
• Detecting and measuring multiple biomarkers non-invasively with a single device
• Monitoring biomarkers on a routine, round-the-clock, near real-time basis
• Creating new opportunities to enhance multiple clinical workflows
In addition to monitoring individual biomarkers, understanding how these biomarkers interact with each other and with other factors is equally critical. Our analytics and AI have the potential to identify patterns for individual biomarkers and deliver a holistic assessment of a person’s overall health and well-being.
Continuous health monitoring is the next evolution for medical device manufacturers and the healthcare industry. Rockley’s ability to deliver real-time insights could have a transformative impact on personal health and well-being — from day-to-day health management to the early detection of diseases. Armed with these insights, consumers could make better-informed decisions about their health and lifestyle, and healthcare providers could make better-informed decisions for their patients.
